These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19324023)
1. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators. Yu S; Wang MW; Yao X; Chan FL Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023 [TBL] [Abstract][Full Text] [Related]
2. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells. Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
4. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. Lamb LE; Knudsen BS; Miranti CK J Cell Sci; 2010 Jan; 123(Pt 2):266-76. PubMed ID: 20048343 [TBL] [Abstract][Full Text] [Related]
6. Suppression of mutant androgen receptors by flutamide. Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase. Kim KH; Dobi A; Shaheduzzaman S; Gao CL; Masuda K; Li H; Drukier A; Gu Y; Srikantan V; Rhim JS; Srivastava S Prostate Cancer Prostatic Dis; 2007; 10(1):30-8. PubMed ID: 17075604 [TBL] [Abstract][Full Text] [Related]
8. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells. Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249 [TBL] [Abstract][Full Text] [Related]
10. Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Tokar EJ; Ancrile BB; Cunha GR; Webber MM Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690 [TBL] [Abstract][Full Text] [Related]
11. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay. Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883 [TBL] [Abstract][Full Text] [Related]
13. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context. Simon S; Mueller SO Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649 [TBL] [Abstract][Full Text] [Related]
14. Androgen induction of in vitro prostate cell differentiation. Whitacre DC; Chauhan S; Davis T; Gordon D; Cress AE; Miesfeld RL Cell Growth Differ; 2002 Jan; 13(1):1-11. PubMed ID: 11801526 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR. Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421 [TBL] [Abstract][Full Text] [Related]
16. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Wu CT; Altuwaijri S; Ricke WA; Huang SP; Yeh S; Zhang C; Niu Y; Tsai MY; Chang C Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12679-84. PubMed ID: 17652515 [TBL] [Abstract][Full Text] [Related]
17. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Simanainen U; McNamara K; Gao YR; Handelsman DJ Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880 [TBL] [Abstract][Full Text] [Related]
18. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity. Guth SE; Böhm S; Mussler BH; Eisenbrand G Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179 [TBL] [Abstract][Full Text] [Related]
19. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Térouanne B; Tahiri B; Georget V; Belon C; Poujol N; Avances C; Orio F; Balaguer P; Sultan C Mol Cell Endocrinol; 2000 Feb; 160(1-2):39-49. PubMed ID: 10715537 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1. Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]